BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19575518)

  • 1. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk.
    Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518
    [No Abstract]   [Full Text] [Related]  

  • 2. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 3. [The revival of an old diagnostic marker: C-reactive protein].
    Sela B
    Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
    [No Abstract]   [Full Text] [Related]  

  • 4. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond cholesterol. Inflammation is emerging as a major risk factor--and not just in heart disease.
    Park A
    Time; 2002 Nov; 160(22):74-5. PubMed ID: 12463072
    [No Abstract]   [Full Text] [Related]  

  • 6. Bringing clarity to CRP testing. Wider use is in the offing for this simple blood test to gauge cardiac risk.
    Harv Heart Lett; 2010 Mar; 20(7):3. PubMed ID: 20586126
    [No Abstract]   [Full Text] [Related]  

  • 7. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of hs-CRP measurements in the current cardiovascular risk assessment.
    García-Moll X; Ordóñez-Llanos J
    Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499
    [No Abstract]   [Full Text] [Related]  

  • 9. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
    Biasucci LM
    Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
    [No Abstract]   [Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
    Maseri A
    Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum C-reactive protein as a marker for wellness assessment.
    Kao PC; Shiesh SC; Wu TJ
    Ann Clin Lab Sci; 2006; 36(2):163-9. PubMed ID: 16682512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health screening packages: the place of measuring C-reactive protein.
    Wong MS
    Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hs-CRP measurements in the current cardiovascular risk assessment.
    Levinson SS; Elin RJ
    Clin Chim Acta; 2005 Jun; 356(1-2):225-6. PubMed ID: 15936322
    [No Abstract]   [Full Text] [Related]  

  • 17. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of the prognostic inflammatory and nutritional index (PINI) in a haemodialysis population.
    Dessì M; Noce A; Agnoli A; De Angelis S; Fuiano L; Tozzo C; Taccone-Gallucci M; Fuiano G; Federici G
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):811-5. PubMed ID: 19361965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.